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Near infrared spectroscopy (NIRS) is a non-invasive
method for monitoring hemoglobin oxygen saturation
within the microvessels. It is therefore also sometimes
(erroneously) referred to as a measure of tissue oxygena-
tion. By using self-adhesive optodes on the body surface,
measurements can be taken in tissues below the skin up to a
depth of 3–4 cm. The near infrared light (unlike visible
light) even penetrates bone tissue, allowing measurement
of regional cerebral oxygenation (SrcO2). There are nu-
merous devices using NIRS technology available on the
market, and the main applications for use include
monitoring of SrcO2 during cardiothoracic and vascular
(particularly carotid artery) surgery, as well as non-cardiac
surgery that is performed in the sitting or so-called beach
chair position [1]. Another widespread use is the assess-
ment of SrcO2 in neonates and preterm infants [2]. Fur-
thermore, there have been attempts to use peripheral tissue
oxygenation (SptO2) measurements by NIRS for guiding
therapy and predicting outcome in emergency medicine
(both pre-hospital and emergency room use) and in the
perioperative setting [3]. Finally, the ability to measure
SptO2 at different sites [4] raised interest in researchers to
look at physiological changes, e.g. during exercise, in
musculature of the leg or arm. For this, a special
provocation test (the vascular occlusion test (VOT) by in-
flating a tourniquet proximal to the measurement site) has
been developed. The VOT looks at the rate of deoxy-
genation during ischemia (vascular occlusion), which is
considered as a measure of muscle and mitochondrial
oxygen consumption, and at the rate of reoxygenation
during reperfusion, reflecting the reactivity of the micro-
circulation [5].
The Journal of Clinical Monitoring and Computing
(JCMC) has become an ideal platform for publishing
NIRS-related research, as reflected by an increasing num-
ber of articles published in the recent years. This article
will review two papers on peripheral (SptO2) and two pa-
pers on cerebral hemoglobin oxygen saturation (SrcO2)
published last year in the JCMC.
1 NIRS for measuring peripheral hemoglobin
oxygen saturation
The first two articles focus on a comparison of different
devices measuring SptO2. Why is that an issue at all? Let’s
go back in time: Twenty years ago, with the first appear-
ance of pulse oximeters in clinical use to measure periph-
eral arterial oxygen saturation (SaO2), there were several
companies that developed and marketed such devices,
which in turn incorporated different technologies (regard-
ing wavelength used, measurement site etc.). As a conse-
quence, at that time SaO2 had to be interpreted in view of
the device used, and their readings could differ by several
percentage points in individual patients. Nowadays, after
standardization and technical progress of pulse oximeter
technologies, no one cares any longer with what device a
given SaO2 is measured, since variation between different
vendors has become negligible. With NIRS technology,
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this standardisation process has still to be initiated, and we
are currently confronted with a huge variety of devices
measuring regional hemoglobin oxygen saturation by using
(one to four) different wavelengths, and come with multi-
ple shaped optodes or sensors intended to be used at dif-
ferent anatomic regions (forehead, thenar eminence,
somatic organs, muscle etc.). This creates an area of
validation research of different NIRS applications, two
examples of which are summarized in the following
chapter.
The first study compares the use of two NIRS devices on
SptO2 on the leg muscles of healthy human volunteers, with
and without performing exercise [6]. Of note, only one of
these devices (the InSpectra, Hutchinson Technologies) is
proposed for this application, while the other one (the Invos
4100, Somanetics) is primarily used for measuring SrcO2.
Consequently, due to these different applications, the au-
thors found a significant difference in muscle hemoglobin
oxygen saturation of slightly more than 10 % already at
baseline (resting conditions), with the InSpectra showing the
higher values (87 ± 8 vs. 76 ± 6 %). The former was in
close agreement with baseline values (86 ± 6 %) observed
with the same device in 160 patients under general anaes-
thesia [7]. During exercise, muscle hemoglobin oxygen
saturation decreased immediately with both devices, to
values close to zero (InSpectra) or slightly above 20 %
(Invos) [6]. This decrease was reversible after cessation of
exercise, with slight hyperaemia of 8 % (InSpectra) and
18 % above baseline values (Invos), respectively. The au-
thors also performed a vascular occlusion test, which re-
vealed similar results as the exercise test. Finally, they
looked at the influence of skin and subcutaneous tissue
thickness as assessed by ultrasound on the measurements of
both devices and found that the InSpectra, but not the Invos,
was prone to increased skin and subcutaneous tissue thick-
ness as reflected by lower SptO2 values. Since the measuring
depth within a tissue is determined by the distance between
the light-emitting and light-detecting part of the optode, the
smaller distance within the InSpectra sensor (30 mm as
compared to 40 mm in the Invos sensor) might explain its
higher susceptibility to thicker skin and subcutaneous tissue.
The authors conclude that the Invos, although not primarily
designed for this purpose, can be used to detect ex-
perimentally and exercise induced skeletal muscle ischemia
in the human leg, interchangeable with the InSpectra in this
respect [6]. However, the study confirms the abovemen-
tioned differences in sensitivity or calibration between NIRS
devices to detect changes in regional hemoglobin oxygen
saturation.
In the second study looking at peripheral hemoglobin
oxygen saturation the authors compared the ability of three
NIRS devices (Invos 5100C, Nonin Equanox 7600, and
Fore-Sight, CASMed), all of which are primarily marketed
for cerebral and somatic use, to measure SptO2 on the
forearm muscles of healthy human volunteers. [8] The
median readings of the three devices at baseline were
within 6 % points, with Invos giving the highest and Fore-
Sight the lowest steady state values. To test the repeata-
bility of the measurements the sensors were repositioned
20 times on the forearm during hemodynamic steady state
conditions. The repeatability of Fore-Sight was best, while
that of Equanox was worst, with no difference between
same-site and various-site repeatability. Also, the authors
repeatedly performed a VOT to induce maximal tissue
deoxygenation and to evaluate the dynamic properties of
the three NIRS devices. The slopes of desaturation were
steepest with Equanox. Furthermore, Equanox and Invos
often reached their lower boundary values during ischemia
at a level of 20–30 % while Fore-Sight showed continuing
desaturation, likely best representing truly changing oxy-
genation. This difference in dynamics found in SptO2
measurements on the arm might also apply to measure-
ments on the forehead, suggesting that differences in so-
called removal of extra-cranial tissue contamination as
presented in a recent study [9] could be simply a matter of
different sensitivity of NIRS devices to overall oxygena-
tion changes in the tissue, as elegantly discussed by the
authors. The study has several clinical implications and
consequences when it comes to choosing a particular NIRS
device: when NIRS oximetry is intended to be used for
trend monitoring, the repeatability of measurement is less
important. If in addition the sensitivity of a NIRS device to
changes in hemoglobin oxygen saturation is low, the risk of
undetected true hypoxia will be high. However, if NIRS is
to be used as a spot measurement (e.g. in the emergency
room) or if the monitoring is started when the patient status
is uncertain (e.g. in the ICU or OR in a deteriorating patient
without having a baseline value), a good repeatability of
measurement or a close proximity to absolute (true) values
becomes more important. Since high sensitivity comes at
the expense of good repeatability, a pragmatic approach
would be to care less about the closeness to the ‘true’
values, but to settle for the device with the best combina-
tion of repeatability and sensitivity to changing oxygena-
tion [8].
2 NIRS for measuring cerebral hemoglobin
oxygen saturation
The most commonly used application for NIRS technology
is monitoring cerebral hemoglobin oxygen saturation
(SrcO2). A recently developed use includes patients un-
dergoing arthroscopic shoulder surgery in the sitting posi-
tion, which is preferred in some centers despite the danger
of hemodynamic instability for the sake of better surgical
218 J Clin Monit Comput (2015) 29:217–220
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conditions. Although it is known that SrcO2 is lower under
those conditions as compared to the alternative lateral de-
cubitus position, the clinical relevant question arises whe-
ther intravenous anesthesia or inhalational anesthesia is
superior when it comes to preserving cerebral oxygenation.
This question was investigated in a recent trial, in which 40
patients were randomized to receive either propofol or
desflurane, both titrated to similar anesthetic depth as ob-
tained by bispectral index (BIS), resulting also in similar
hemodynamics [10]. While SrcO2 significantly decreased
in both groups in the first minutes after patients were lo-
cated from the supine to the sitting position, values re-
mained significantly higher in the desflurane group as
compared to the propofol group, despite lower blood
pressures. Furthermore, cerebral desaturations, defined as
SrcO2 below 75 % of individual baseline values, occurred
in two patients of the propofol group but in none of the
desflurane group. Unfortunately, measurements were
stopped 9 min after positioning of the patients, preventing
conclusions on the intraoperative course of SrcO2 as well
as on-going differences between anesthetic agents. The
authors conclude that desflurane preserved cerebral oxy-
genation better than propofol at equipotent anesthetic
concentrations [10]. These observations are surprising at
first sight, since it is long known that volatile anesthetics
impair autoregulation of cerebral blood flow more than
propofol [11]. The authors speculate that desflurane (unlike
propofol) induced cerebral vasodilation and thus increased
cerebral blood flow (CBF), which in turn compensates the
reduction in CBF following installation of the sitting po-
sition. Otherwise, we may also speculate that the negative
impact of propofol on venous return and thus cardiac
output is huge in the present posture due to the venodilator
effect of the drug.
Another example of the clinical applicability of NIRS
technology to measure SrcO2 is presented in a case series
of 20 patients undergoing major abdominal or urological
surgery under general anaesthesia [12]. The authors used
controlled hypotension induced by nitroglycerin (NTG) in
order to minimize blood loss and optimise surgical condi-
tions. Vasodilation with NTG reduced MAP by about 20 %
(from 90 ± 14 to 72 ± 14 mmHg), whereas it increased
SrcO2 in all patients by an average between 15 and 21 %.
Although the authors did not measure blood flow (e.g.
cardiac output) and did not report what NIRS device they
used, these findings demonstrate that blood pressure and
tissue perfusion are not always related in a linear, positive
fashion (uncoupling phenomenon). The authors discuss as
a potential confounder that the volatile anaesthetics used
might have led to luxury perfusion of the monitored brain
area while diverting blood away from potentially ischemic
regions. [12] Nevertheless, this case series shows that
NIRS monitoring can be used to ensure the adequacy of
tissue oxygenation during controlled hypotension and ex-
pands the scope of conventional hemodynamic monitoring
in this respect. This way it may contribute to improve
patient’s safety in case of macro-microcirculatory
decoupling.
3 Interpretation of SrcO2 values
Since there is no consensus about what should be consid-
ered ‘‘normal values’’ for cerebral hemoglobin oxygen
saturation, the authors of the previous study [8] come up
with a very interesting calculation: Assuming that a jugular
bulb saturation (SjbO2, the gold standard for assessing
cerebral hypoxemia) below 50 % indicates cerebral is-
chemia, then with a ratio between arterial and venous blood
volumes of 25:75 contributing to the SrcO2 signal dis-
played on the monitor, as most NIRS devices adopt, we can
calculate which readings actually indicate cerebral is-
chemia and which readings may assure us that this is not
the case [8]. In detail, if the SaO2 is 95 % and SjbO2 50 %,
the resulting SrcO2 should be 61 %, which can be con-
sidered as ‘‘normal’’. Thus with a standard deviation of
5 % a SrcO2 measurement should be below 52 % (61-
1.96 9 5 %) to be more than 95 % certain that the tissue is
actually ischemic and above 71 % (61 ? 1.96 9 5 %) to
be certain that it is not, implying a large ‘‘grey zone’’ of
SrcO2 values where its diagnostic ability is inconclusive
[13]. On the other hand, changing of the body position (e.g.
head-up or head-down tilting) may change the ratio be-
tween arterial and venous blood volumes of 25:75, so that
for instance decreases in the SrcO2 readings are simply the
results of an increased proportion of venous blood con-
tributing to the signal, rather than a true change in cerebral
tissue oxygenation. In this respect, the higher SrcO2 values
after raising patients to the sitting position during desflu-
rane anesthesia in the abovementioned study [10] could be
interpreted as evidence for cerebral arterial vasodilation
under desflurane and maintained cerebrovascular tone un-
der propofol anesthesia.
In conclusion, until a standardization of NIRS devices
has been effectuated, the clinical context may influence the
choice of the adequate NIRS device for a specific purpose.
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